What is the KROS stock price prediction for next 2 weeks?

According to our price prediction algorithm,Keros Therapeutics, Inc. (KROS) price will be around $8.19 in the next 2 weeks. This means it will decrease by -27.863436123348016 from the last closing price. This prediction may vary from other time period filters for KROS stock.

What can be the highest Possible price of KROS stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, KROS can achieve the highest price of $8.61 which is -24.10535959354858 lower than last closing price. This prediction may vary from other time period filters for KROS stock.

What can be the lowest Possible price of KROS stock in next 2 weeks?

As per the forecast and algorithmic analysis, KROS stock price can be as low as $7.79 which is -31.35151172844089 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for KROS stock.

Will KROS stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that KROS stock will lose-27.863436123348016 in the next 2 weeks. This prediction may vary from other time period filters for KROS stock.

What is KROS stock last closing price?

Last closing price of KROS stock was $11.58.

What is KROS stock price prediction?

KROS stock price prediction means predicting the future closing prices of KROS stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of KROS stock in a certain time period.

How we predict KROS stock future prices?

If you are searching for KROS stock forecast, analysis or price prediction, then you might be wondering what Keros Therapeutics, Inc. (KROS) will do in the future. Our KROS price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This KROS price prediction will likely answer most of your questions.

How frequent we update KROS stock predictions?

We are updating the forecasts for the KROS stock on daily basis.

Is using ML forecasting for KROS stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for KROS stock same for all the time periods?

No, the prediction for KROS stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Keros Therapeutics, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$11.58-25.39%Since 2 Weeks

Predicted Price$8.19-27.86%For 2 Weeks

Upper Predicted Price$8.61-24.11%For 2 Weeks

Lower Predicted Price$7.79-31.35%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of KROS will decline by -27.86% over the next 2 Weeks and hit $8.19 by Monday, March 23, 2026. In that time frame, KROS's share price is expected to range between $7.79 and $8.61.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Mar 23, 2026	7.79	8.19	8.61
Mar 20, 2026	8.01	8.42	8.84
Mar 19, 2026	8.39	8.78	9.19
Mar 18, 2026	8.58	8.99	9.38
Mar 17, 2026	8.81	9.20	9.60
Mar 16, 2026	9.32	9.70	10.11
Mar 13, 2026	9.57	9.93	10.31
Mar 12, 2026	9.93	10.29	10.67
Mar 11, 2026	10.12	10.50	10.85
Mar 10, 2026	10.34	10.71	11.08

KROS shares rose +2.03% in Tuesday, March 10, 2026's trading session, rising from a previous close of $11.35 to move at $11.58. The stock demonstrated notable intraday movement (see KROS's key stats for a full breakdown), fluctuating between $10.86 and $11.74, a +8.10% trading range. While recent weeks have seen some volatility, KROS has managed to secure a -26.29% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 657.32K shares changing hands, 20.42K fewer than the previous session. This amounted to $7.61M in total market activity.

Will KROS Continue Its Downward Trend?

According to analyst ratings and projections for KROS, Keros Therapeutics, Inc. shares are anticipated to decrease by -34.43%, potentially reaching $8.61 per share by March 23, 2026. Short-term technical indicators for KROS currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 23 negative trading days within the past 30 sessions. Based on the KROS stock forecast, now is not the best time to buy KROS stock because its current trading price is +41.44% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on KROS covering social and institutional perspectives.

KROS Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into KROS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 17.07% to 23.50%) suggest the stock is in a strong bearish momentum phase. The 50-day RSI, at 36.42%, hints at potential weakness developing in the medium term. Meanwhile, the 100-day RSI, at 42.39%, maintains a neutral outlook for the long term. Insights into KROS's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Keros Therapeutics Short-Term Forecasts

KROS Forecast For Next 5 Days

Our algorithm anticipates Keros Therapeutics (KROS) stock could hit $10.32 by Mar 17, 2026. This represents a -10.89% fall from today's price, following a -2.38% change over the past five days.

KROS Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Keros Therapeutics, Inc. (KROS) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $9.30, which would mean a -19.69% decrease from the current price of $11.58. Projections for this period range from a high of $12.33 to a low of $6.31.

KROS Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Keros Therapeutics's price over the next three months point to a drop. KROS stock is expected to peak at $14.33 on Mar 10, 2026 before potentially dipping to $4.88 on Jun 10, 2026. On average, KROS is likely to trade around $10.33 in the coming 90 days.

Keros Therapeutics Stock Forecast 2025

Based on our predictive models, Keros Therapeutics (KROS) is expected to trade between $0.00 and $14.33 throughout 2026. This would result in an average price of $9.18, potentially offering investors a -20.73% return from current levels.

Keros Therapeutics, Inc. Monthly Forecast 2026–2027

March 2026

According to our latest forecast models, Keros Therapeutics, Inc. (KROS) is positioned to show a strong performance in March 2026. The price is predicted to move between $9.55 and $14.33, settling at an average of $11.56. This could translate to a -0.17% loss.

April 2026

Based on current market signals, Keros Therapeutics, Inc. is projected to trend april 2026. We forecast a trading range from $8.53 to $13.58, with a likely average price of $11.21. Investors could expect a potential return of -3.20%.

May 2026

Our predictive algorithms indicate Keros Therapeutics, Inc. stock may see a shift in May 2026. The expected range spans $5.69–$11.92, with an average target of $9.58. This represents a cautious outlook and a possible loss of -17.27%.

June 2026

Analyzing established trends, Keros Therapeutics, Inc. looks set to move in June 2026. Projections place the stock between $3.79 and $9.20, averaging around $7.04. This suggests a -39.21% loss from current levels.

July 2026

Market indicators suggest Keros Therapeutics, Inc. could experience notable changes during July 2026. Prices could fluctuate within $2.63 to $8.47, with a midpoint forecast of $7.15. The stock might deliver a -38.26% loss.

August 2026

Forecasting for August 2026, models estimate that Keros Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.41 and $7.75, averaging $5.78. This signals a cautious trajectory with potential returns around -50.09%.

September 2026

According to our latest forecast models, Keros Therapeutics, Inc. (KROS) is positioned to show a strong performance in September 2026. The price is predicted to move between $0.00 and $8.63, settling at an average of $8.67. This could translate to a -25.13% loss.

October 2026

Based on current market signals, Keros Therapeutics, Inc. is projected to trend october 2026. We forecast a trading range from $0.00 to $8.61, with a likely average price of $9.09. Investors could expect a potential return of -21.50%.

November 2026

Our predictive algorithms indicate Keros Therapeutics, Inc. stock may see a shift in November 2026. The expected range spans $0.00–$13.17, with an average target of $11.34. This represents a cautious outlook and a possible loss of -2.07%.

December 2026

Analyzing established trends, Keros Therapeutics, Inc. looks set to move in December 2026. Projections place the stock between $0.00 and $13.48, averaging around $10.94. This suggests a -5.53% loss from current levels.

January 2027

Market indicators suggest Keros Therapeutics, Inc. could experience notable changes during January 2027. Prices could fluctuate within $0.00 to $14.70, with a midpoint forecast of $10.51. The stock might deliver a -9.24% loss.

February 2027

Forecasting for February 2027, models estimate that Keros Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $16.22, averaging $10.93. This signals a cautious trajectory with potential returns around -5.61%.

March 2027

According to our latest forecast models, Keros Therapeutics, Inc. (KROS) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.00 and $15.49, settling at an average of $10.18. This could translate to a -12.09% loss.

KROS's history of dividends and stock splits also plays a role in long-term investor confidence.